Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Burnham

Showing results (81-90 of 107) with videos related to

Pageof 11
Sort By:
Geroscience|April 21, 2022
Comprehensive analysis of epigenetic clocks reveals associations between disproportionate biological ageing and hippocampal volumeLidija Milicic, Michael Vacher, Tenielle Porter, et al.
Metallomics : Integrated Biometal Science|March 29, 2014
Decreased serum zinc is an effect of ageing and not Alzheimer's diseaseAlan Rembach, Dominic J Hare, James D Doecke, et al.
Alzheimer'S & Dementia (New York, N. Y.)|January 3, 2025
Application of the revised criteria for diagnosis and staging of Alzheimer's disease: Drug development and clinical practiceClifford R Jack, Ana Graf, Samantha C Burnham, et al.
JAMA Neurology|January 23, 2018
Association of β-Amyloid and Apolipoprotein E ε4 With Memory Decline in Preclinical Alzheimer DiseaseYen Ying Lim, Pawel Kalinowski, Robert H Pietrzak, et al.
Journal of Alzheimer'S Disease : JAD|July 11, 2022
Visually Identified Tau 18F-MK6240 PET Patterns in Symptomatic Alzheimer's DiseaseNatasha Krishnadas, Kun Huang, Stephanie A Schultz, et al.
Journal of Alzheimer'S Disease : JAD|September 25, 2015
Novel Statistically-Derived Composite Measures for Assessing the Efficacy of Disease-Modifying Therapies in Prodromal Alzheimer's Disease Trials: An AIBL StudySamantha C Burnham, Nandini Raghavan, William Wilson, et al.
Journal of Alzheimer'S Disease : JAD|December 17, 2013
Plasma amyloid-β levels are significantly associated with a transition toward Alzheimer's disease as measured by cognitive decline and change in neocortical amyloid burdenAlan Rembach, Andrew D Watt, William J Wilson, et al.
Journal of Alzheimer'S Disease : JAD|November 10, 2018
Utility of an Alzheimer's Disease Risk-Weighted Polygenic Risk Score for Predicting Rates of Cognitive Decline in Preclinical Alzheimer's Disease: A Prospective Longitudinal StudyTenielle Porter, Samantha C Burnham, Lidija Milicic, et al.
Neurobiology of Aging|February 5, 2019
Klotho allele status is not associated with Aβ and APOE ε4-related cognitive decline in preclinical Alzheimer's diseaseTenielle Porter, Samantha C Burnham, Lidija Milicic, et al.
Neurology|August 19, 2016
Predicting Alzheimer disease from a blood-based biomarker profile: A 54-month follow-upSamantha C Burnham, Christopher C Rowe, David Baker, et al.
Pageof 11

Showing results (81-90 of 107) with videos related to

Sort By:
Pageof 11
Geroscience|April 21, 2022
Comprehensive analysis of epigenetic clocks reveals associations between disproportionate biological ageing and hippocampal volumeLidija Milicic, Michael Vacher, Tenielle Porter, et al.
Metallomics : Integrated Biometal Science|March 29, 2014
Decreased serum zinc is an effect of ageing and not Alzheimer's diseaseAlan Rembach, Dominic J Hare, James D Doecke, et al.
Alzheimer'S & Dementia (New York, N. Y.)|January 3, 2025
Application of the revised criteria for diagnosis and staging of Alzheimer's disease: Drug development and clinical practiceClifford R Jack, Ana Graf, Samantha C Burnham, et al.
JAMA Neurology|January 23, 2018
Association of β-Amyloid and Apolipoprotein E ε4 With Memory Decline in Preclinical Alzheimer DiseaseYen Ying Lim, Pawel Kalinowski, Robert H Pietrzak, et al.
Journal of Alzheimer'S Disease : JAD|July 11, 2022
Visually Identified Tau 18F-MK6240 PET Patterns in Symptomatic Alzheimer's DiseaseNatasha Krishnadas, Kun Huang, Stephanie A Schultz, et al.
Journal of Alzheimer'S Disease : JAD|September 25, 2015
Novel Statistically-Derived Composite Measures for Assessing the Efficacy of Disease-Modifying Therapies in Prodromal Alzheimer's Disease Trials: An AIBL StudySamantha C Burnham, Nandini Raghavan, William Wilson, et al.
Journal of Alzheimer'S Disease : JAD|December 17, 2013
Plasma amyloid-β levels are significantly associated with a transition toward Alzheimer's disease as measured by cognitive decline and change in neocortical amyloid burdenAlan Rembach, Andrew D Watt, William J Wilson, et al.
Journal of Alzheimer'S Disease : JAD|November 10, 2018
Utility of an Alzheimer's Disease Risk-Weighted Polygenic Risk Score for Predicting Rates of Cognitive Decline in Preclinical Alzheimer's Disease: A Prospective Longitudinal StudyTenielle Porter, Samantha C Burnham, Lidija Milicic, et al.
Neurobiology of Aging|February 5, 2019
Klotho allele status is not associated with Aβ and APOE ε4-related cognitive decline in preclinical Alzheimer's diseaseTenielle Porter, Samantha C Burnham, Lidija Milicic, et al.
Neurology|August 19, 2016
Predicting Alzheimer disease from a blood-based biomarker profile: A 54-month follow-upSamantha C Burnham, Christopher C Rowe, David Baker, et al.
Pageof 11